EX-4.2



 Exhibit 4.2 

OKTA, INC. 
 AMENDED AND
RESTATED INVESTORS’ RIGHTS AGREEMENT 
 July 31, 2015 







 TABLE OF CONTENTS 

 

									
	 	 	 	  	 	  	Page	 
			
	 1.
	 	 Registration Rights
	  	 	1	  
		 	 1.1
	  	 Definitions
	  	 	1	  
		 	 1.2
	  	 Request for Registration
	  	 	3	  
		 	 1.3
	  	 Company Registration
	  	 	4	  
		 	 1.4
	  	 Form S-3 Registration
	  	 	5	  
		 	 1.5
	  	 Obligations of the Company
	  	 	7	  
		 	 1.6
	  	 Information from Holder
	  	 	10	  
		 	 1.7
	  	 Expenses of Registration
	  	 	10	  
		 	 1.8
	  	 Delay of Registration
	  	 	11	  
		 	 1.9
	  	 Indemnification
	  	 	11	  
		 	 1.10
	  	 Reports Under the 1934 Act
	  	 	13	  
		 	 1.11
	  	 Assignment of Registration Rights
	  	 	13	  
		 	 1.12
	  	 Limitations on Subsequent Registration Rights
	  	 	14	  
		 	 1.13
	  	 “Market Stand-Off” Agreement
	  	 	14	  
		 	 1.14
	  	 Termination of Registration Rights
	  	 	15	  
			
	 2.
	 	 Covenants of the Company
	  	 	15	  
		 	 2.1
	  	 Delivery of Financial Statements
	  	 	15	  
		 	 2.2
	  	 Inspection
	  	 	16	  
		 	 2.3
	  	 Termination of Information and Inspection Covenants
	  	 	16	  
		 	 2.4
	  	 Right of First Offer
	  	 	16	  
		 	 2.5
	  	 Proprietary Information and Inventions Agreements
	  	 	18	  
		 	 2.6
	  	 Employee Agreements
	  	 	18	  
		 	 2.7
	  	 Insurance
	  	 	18	  
		 	 2.8
	  	 Observer Rights
	  	 	18	  
		 	 2.9
	  	 FCPA; OFAC
	  	 	19	  
		 	 2.10
	  	 Green Dot Corporation
	  	 	19	  
		 	 2.11
	  	 Investment; Acknowledgment
	  	 	19	  
		 	 2.12
	  	 Termination of Covenants
	  	 	20	  
			
	 3.
	 	 Miscellaneous
	  	 	20	  
		 	 3.1
	  	 Successors and Assigns
	  	 	20	  
		 	 3.2
	  	 Governing Law
	  	 	20	  
		 	 3.3
	  	 Counterparts; Facsimile
	  	 	20	  
		 	 3.4
	  	 Titles and Subtitles
	  	 	20	  
		 	 3.5
	  	 Notices
	  	 	20	  
		 	 3.6
	  	 Expenses
	  	 	21	  
		 	 3.7
	  	 Entire Agreement; Amendments and Waivers
	  	 	21	  
		 	 3.8
	  	 Severability
	  	 	21	  
		 	 3.9
	  	 Aggregation of Stock
	  	 	21	  
		 	 3.10
	  	 Additional Investors
	  	 	21	  
		 	 3.11
	  	 Termination of Prior Agreement
	  	 	21	  


  
 i 








 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of July 31, 2015, by and among
OKTA, INC., a Delaware corporation (the “Company”) and the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor” and collectively as the
“Investors. 
 RECITALS 

WHEREAS, certain of the Investors (the “Existing Investors”) hold shares of the Company’s Series A Preferred
Stock (the “Series A Preferred Stock”), Series B Preferred Stock (the “Series B Preferred Stock”), Series C Preferred Stock (the “Series C Preferred Stock”), Series D
Preferred Stock (the “Series D Preferred Stock”), Series E Preferred Stock (the “Series E Preferred Stock”) and/or shares of Common Stock issued upon conversion thereof and possess registration
rights, information rights, rights of first offer and other rights pursuant to an Amended and Restated Investors’ Rights Agreement dated as of May 23, 2014 by and among the Company and such Existing Investors (the “Prior
Agreement”); 
 WHEREAS, subject to certain exceptions, the Prior Agreement may be amended, and any provision therein
waived, with the consent of the Company and the holders of a majority of the outstanding Registrable Securities (as such term is defined in the Prior Agreement); 

WHEREAS, the Existing Investors as holders of a majority of the outstanding Registrable Securities (as such term is defined in the
Prior Agreement) of the Company desire to terminate the Prior Agreement and to accept the rights created pursuant hereto in lieu of the rights granted to them under the Prior Agreement; and 

WHEREAS, certain Investors are parties to the Series F Preferred Stock Purchase Agreement of even date herewith by and among the
Company and certain of the Investors (the “Series F Agreement”), which provides that as a condition to the closing of the sale of the Series F Preferred Stock (the “Series F Preferred Stock” and collectively with
the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock, the “Preferred Stock”), this Agreement must be executed and delivered by such Investors,
Existing Investors holding a majority of the outstanding Registrable Securities (as such term is defined in the Prior Agreement) of the Company, and the Company; 

NOW, THEREFORE, in consideration of the mutual promises and covenants set forth herein, the Existing Investors hereby agree that the
Prior Agreement shall be superseded and replaced in its entirety by this Agreement, and the parties hereto further agree as follows: 
 1.
Registration Rights. The Company covenants and agrees as follows: 
 1.1 Definitions. For purposes of this Agreement: 

(a) The term “Act” means the Securities Act of 1933, as amended. 







 (b) The term “Affiliate” means, with respect to any specified person, any other
person who or which, directly or indirectly, controls, is controlled by, or is under common control with such specified person, including, without limitation, any general partner, officer, director or manager of such person and any venture capital
fund now or hereafter existing that is controlled by one or more general partners or managing members of, or is under common investment management with, such person. 

(c) The term “Form S-3” means such form under the Act as in effect on the date
hereof or any registration form under the Act subsequently adopted by the SEC that permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC. 

(d) The term “Free Writing Prospectus” means a free-writing prospectus, as defined in Rule 405 promulgated under the Act.

 (e) The term “Holder” means any person owning or having the right to acquire Registrable Securities or any assignee
thereof in accordance with Section 1.11 hereof. 
 (f) The term “Initial Offering” means the Company’s first
firm commitment underwritten public offering of its Common Stock under the Act. 
 (g) The term “1934 Act” means the
Securities Exchange Act of 1934, as amended. 
 (h) The terms “register,” “registered,” and
“registration” refer to a registration effected by preparing and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or
document. 
 (i) The term “Registrable Securities” means (i) the Common Stock issuable or issued upon conversion of
the Preferred Stock and (ii) any Common Stock of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution with respect to, or in exchange for,
or in replacement of, the shares referenced in (i) above, excluding in all cases, however, any Registrable Securities sold by a person in a transaction in which his rights under this Section 1 are not assigned. In addition, the number of
shares of Registrable Securities outstanding shall equal the aggregate of the number of shares of Common Stock outstanding that are, and the number of shares of Common Stock issuable pursuant to then exercisable or convertible securities that are,
Registrable Securities. 
 (j) The term “Restated Certificate” shall mean the Company’s Restated Certificate of
Incorporation, as amended and/or restated from time to time. 
 (k) The term “Rule 144” shall mean Rule 144 under the Act.

 (l) The term “Rule 144(b)(1)(i)” shall mean subsection (b)(1)(i) of Rule 144 under the Act as it applies to persons who
have held shares for more than one (1) year. 

  
 2 








 (m) The term “Rule 405” shall mean Rule 405 under the Act. 

(n) The term “SEC” shall mean the Securities and Exchange Commission. 

1.2 Request for Registration. 

(a) Subject to the conditions of this Section 1.2, if the Company shall receive at any time after the earlier of (i) five
(5) years after the date of this Agreement or (ii) six (6) months after the effective date of the Initial Offering, a written request from the Holders of twenty-five percent (25%) or more of the Registrable Securities then
outstanding (for purposes of this Section 1.2, the “Initiating Holders”) that the Company file a registration statement under the Act covering the registration of Registrable Securities with an anticipated aggregate offering
price of at least $15,000,000, then the Company shall, within twenty (20) days of the receipt thereof, give written notice of such request to all Holders, and subject to the limitations of this Section 1.2, use all commercially reasonable
efforts to effect, as soon as practicable, the registration under the Act of all Registrable Securities that the Holders request to be registered in a written request received by the Company within twenty (20) days of the mailing of the
Company’s notice pursuant to this Section 1.2(a). 
 (b) If the Initiating Holders intend to distribute the Registrable
Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 1.2, and the Company shall include such information in the written notice referred to in
Section 1.2(a). In such event the right of any Holder to include its Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable
Securities in the underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall
enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting by the Company (which underwriter or underwriters shall be reasonably acceptable to those Initiating Holders holding a
majority of the Registrable Securities held by all Initiating Holders). Notwithstanding any other provision of this Section 1.2, if the underwriter advises the Company that marketing factors require a limitation on the number of securities
underwritten (including Registrable Securities), then the Company shall so advise all Holders of Registrable Securities that would otherwise be underwritten pursuant hereto, and the number of shares that may be included in the underwriting shall be
allocated to the Holders of such Registrable Securities pro rata based on the number of Registrable Securities held by all such Holders (including the Initiating Holders). In no event shall any Registrable Securities be excluded from such
underwriting unless all other securities are first excluded. Any Registrable Securities excluded or withdrawn from such underwriting shall be withdrawn from the registration. 

(c) Notwithstanding the foregoing, the Company shall not be required to effect a registration pursuant to this Section 1.2: 

(i) in any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting
such registration, unless the Company is already subject to service in such jurisdiction and except as may be required under the Act; or 

  
 3 








 (ii) after the Company has effected two (2) registrations pursuant to this
Section 1.2, and such registrations have been declared or ordered effective; or 
 (iii) during the period starting with the date
sixty (60) days prior to the Company’s good faith estimate of the date of the filing of and ending on a date one hundred eighty (180) days following the effective date of a Company-initiated
registration subject to Section 1.3 below, provided that the Company is actively employing in good faith all commercially reasonable efforts to cause such registration statement to become effective; or 

(iv) if the Initiating Holders propose to dispose of Registrable Securities that may be registered on
Form S-3 pursuant to Section 1.4 hereof; or 
 (v) if the Company shall furnish to
Holders requesting a registration statement pursuant to this Section 1.2 a certificate signed by the Company’s Chief Executive Officer or Chairman of the Board of Directors stating that in the good faith judgment of the Board of Directors
of the Company, it would be seriously detrimental to the Company and its shareholders for such registration statement to be effected at such time, in which event the Company shall have the right to defer such filing for a period of not more than
ninety (90) days after receipt of the request of the Initiating Holders, provided that such right shall be exercised by the Company not more than once in any twelve (12) month period and provided further that the
Company shall not register any securities for the account of itself or any other shareholder during such ninety (90) day period (other than a registration relating solely to the sale of securities of participants in a Company stock plan, a
registration relating to a corporate reorganization or transaction under Rule 145 of the Act, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement
covering the sale of the Registrable Securities, or a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered). 

1.3 Company Registration. 

(a) If (but without any obligation to do so) the Company proposes to register (including for this purpose a registration effected by the
Company for shareholders other than the Holders) any of its stock or other securities under the Act in connection with the public offering of such securities (other than (i) a registration relating to a demand pursuant to Section 1.2 or
(ii) a registration relating solely to the sale of securities of participants in a Company stock plan, a registration relating to a corporate reorganization or transaction under Rule 145 of the Act, a registration on any form that does not
include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities, or a registration in which the only Common Stock being registered is Common Stock issuable
upon conversion of debt securities that are also being registered), the Company shall, at such time, promptly give each Holder written notice of such registration. Upon the written request of each Holder given within twenty (20) days after
mailing of such notice by the Company in accordance with Section 3.5, the Company shall, subject to the provisions of Section 1.3(c), use all commercially reasonable efforts to cause to be registered under the Act all of the Registrable
Securities that each such Holder requests to be registered. 

  
 4 








 (b) Right to Terminate Registration. The Company shall have the right to terminate or
withdraw any registration initiated by it under this Section 1.3 prior to the effectiveness of such registration whether or not any Holder has elected to include securities in such registration. The expenses of such withdrawn registration shall
be borne by the Company in accordance with Section 1.7 hereof. 
 (c) Underwriting Requirements. In connection with any
offering involving an underwriting of shares of the Company’s capital stock, the Company shall not be required under this Section 1.3 to include any of the Holders’ securities in such underwriting unless they accept the terms of the
underwriting as agreed upon between the Company and the underwriters selected by the Company (or by other persons entitled to select the underwriters) and enter into an underwriting agreement in customary form with such underwriters, and then only
in such quantity as the underwriters determine in their sole discretion will not jeopardize the success of the offering by the Company. If the total amount of securities, including Registrable Securities, requested by shareholders to be included in
such offering exceeds the amount of securities sold other than by the Company that the underwriters determine in their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only
that number of such securities, including Registrable Securities, that the underwriters determine in their sole discretion will not jeopardize the success of the offering. In no event shall any Registrable Securities be excluded from such offering
unless all other shareholders’ securities have been first excluded. In the event that the underwriters determine that less than all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable
Securities that are included in such offering shall be apportioned pro rata among the selling Holders based on the number of Registrable Securities held by all selling Holders or in such other proportions as shall mutually be agreed to by all such
selling Holders. Notwithstanding the foregoing, in no event shall the amount of securities of the selling Holders included in the offering be reduced below twenty-five percent (25%) of the total amount of securities included in such offering,
unless such offering is the Initial Offering, in which case the selling Holders may be excluded if the underwriters make the determination described above and no other shareholder’s securities are included in such offering. For purposes of the
preceding sentence concerning apportionment, for any selling shareholder that is a Holder of Registrable Securities and that is a venture capital fund, partnership or corporation, the affiliated venture capital funds, partners, retired partners and
shareholders of such Holder, or the estates and family members of any such partners and retired partners and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single “selling Holder,” and any pro rata
reduction with respect to such “selling Holder” shall be based upon the aggregate amount of Registrable Securities owned by all such related entities and individuals. 

1.4 Form S-3 Registration. In case the Company shall receive from the Holders of at least fifty
percent (50%) of the Registrable Securities (for purposes of this Section 1.4, the “S-3 Initiating Holders”) a written request or requests that the Company effect a registration on
Form S-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders, the Company shall: 

(a) promptly give written notice of the proposed registration, and any related qualification or compliance, to all other Holders; and 

  
 5 








 (b) use all commercially reasonable efforts to effect, as soon as practicable, such registration
and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holders’ Registrable Securities as are specified in such request, together with all or
such portion of the Registrable Securities of any other Holders joining in such request as are specified in a written request given within fifteen (15) days after receipt of such written notice from the Company, provided, however,
that the Company shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 1.4: 

(i) if Form S-3 is not available for such offering by the Holders; 

(ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to
sell Registrable Securities and such other securities (if any) at an aggregate price to the public (net of any underwriters’ discounts or commissions) of less than $10,000,000; 

(iii) if the Company shall furnish to all Holders requesting a registration statement pursuant to this Section 1.4 a certificate signed
by the Company’s Chief Executive Officer or Chairman of the Board of Directors stating that in the good faith judgment of the Board of Directors of the Company, it would be seriously detrimental to the Company and its shareholders for such
registration statement to be effected at such time, in which event the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request of the S-3 Initiating Holders, provided
that such right shall be exercised by the Company not more than once in any twelve (12) month period and provided further that the Company shall not register any securities for the account of itself or any other shareholder during
such ninety (90) day period (other than a registration relating solely to the sale of securities of participants in a Company stock plan, a registration relating to a corporate reorganization or transaction under Rule 145 of the Act, a
registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities, or a registration in which the only Common Stock being
registered is Common Stock issuable upon conversion of debt securities that are also being registered); 
 (iv) if the Company has, within
the twelve (12) month period preceding the date of such request, already effected two (2) registrations on Form S-3 pursuant to this Section 1.4; 

(v) in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to
service of process in effecting such registration, qualification or compliance, unless the Company is already subject to service in such jurisdiction and except as may be required under the Act; 

  
 6 








 (vi) if the Company, within thirty (30) days of receipt of the request of such S-3
Initiating Holders, gives notice of its bona fide intention to effect the filing of a registration statement with the SEC within one hundred twenty (120) days of receipt of such request (other than a registration effected solely to qualify an
employee benefit plan or to effect a business combination pursuant to Rule 145), provided that the Company is actively employing in good faith all commercially reasonable efforts to cause such registration statement to become effective; or

 (vii) during the period starting with the date thirty (30) days prior to the Company’s good faith estimate of the date of the
filing of and ending on a date ninety (90) days following the effective date of a Company-initiated registration subject to Section 1.3 above, provided that the Company is actively employing
in good faith all commercially reasonable efforts to cause such registration statement to become effective. 
 (c) If the S-3 Initiating
Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 1.4 and the Company shall include such
information in the written notice referred to in Section 1.4(a). The provisions of Section 1.2(b) shall be applicable to such request (with the substitution of Section 1.4 for references to Section 1.2). 

(d) Subject to the foregoing, the Company shall file a registration statement covering the Registrable Securities and other securities so
requested to be registered as soon as practicable after receipt of the request or requests of the S-3 Initiating Holders. Registrations effected pursuant to this Section 1.4 shall not be counted as requests for registration effected pursuant to
Section 1.2. 
 1.5 Obligations of the Company. Whenever required under this Section 1 to effect the registration of any
Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) prepare and file with the SEC a registration
statement with respect to such Registrable Securities and use all commercially reasonable efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered
thereunder, keep such registration statement effective for a period of up to one hundred twenty (120) days or, if earlier, until the distribution contemplated in the Registration Statement has been completed; provided, however, that
(i) such 120-day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter of Common Stock (or other securities) of the Company, from selling any securities included in such
registration, and (ii) in the case of any registration of Registrable Securities on Form S-3 that are intended to be offered on a continuous or delayed basis, subject to compliance with applicable SEC rules, such 120-day period shall be
extended for up to sixty (60) days, if necessary, to keep the registration statement effective until all such Registrable Securities are sold; 

(b) prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with
such registration statement as may be necessary to comply with the provisions of the Act with respect to the disposition of all securities covered by such registration statement; 

  
 7 








 (c) furnish to the Holders such number of copies of a prospectus, including a preliminary
prospectus and any Free Writing Prospectus, in conformity with the requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 

(d) use all commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other
securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required under the Act; 

(e) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the managing underwriter of such offering; 
 (f) notify each Holder of Registrable Securities covered by such
registration statement at any time when a prospectus or Free Writing Prospectus (to the extent prepared by or on behalf of the Company) relating thereto is required to be delivered under the Act of the happening of any event as a result of which the
prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the
light of the circumstances then existing, and, at the request of any such Holder, the Company will, as soon as reasonably practicable, file and furnish to all such Holders a supplement or amendment to such prospectus or Free Writing Prospectus (to
the extent prepared by or on behalf of the Company) so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus will not contain an untrue statement of a material fact or omit to state any fact necessary to
make the statements therein not misleading in light of the circumstances under which they were made; 
 (g) cause all such Registrable
Securities registered pursuant to this Section 1 to be listed on a national exchange or trading system and on each securities exchange and trading system on which similar securities issued by the Company are then listed; 

(h) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and a CUSIP number for all
such Registrable Securities, in each case not later than the effective date of such registration; 
 (i) promptly make available for
inspection by the selling Holders, any managing underwriter(s) participating in any disposition pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling
Holders, all financial and other records, pertinent corporate documents, and properties of the Company, and cause the Company’s officers, directors, employees, and independent 

  
 8 








 
accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant, or agent, in each case, as necessary or advisable to verify the accuracy of the
information in such registration statement and to conduct appropriate due diligence in connection therewith; 
 (j) notify each selling
Holder, promptly after the Company receives notice thereof, of the time when such registration statement has been declared effective or a supplement to any prospectus or Free Writing Prospectus forming a part of such registration statement has been
filed; 
 (k) after such registration statement becomes effective, notify each selling Holder of any request by the SEC that the Company
amend or supplement such registration statement or prospectus or Free Writing Prospectus; 
 (l) use its commercially reasonable efforts to
obtain for the underwriters one or more “cold comfort” letters, dated the effective date of the related registration statement (and, if such registration includes an underwritten public offering, dated the date of the closing under the
underwriting agreement), signed by the Company’s independent public accountants in customary form and covering such matters of the type customarily covered by “cold comfort” letters; 

(m) use its commercially reasonable efforts to obtain for the underwriters on the date such securities are delivered to the underwriters for
sale pursuant to such registration a legal opinion of the Company’s outside counsel with respect to the registration statement, each amendment and supplement thereto, the prospectus included therein (including the preliminary prospectus) and
such other documents relating thereto in customary form and covering such matters of the type customarily covered by legal opinions of such nature; 

(n) to the extent the Company is a well-known seasoned issuer (as defined in SEC Rule 405) at the time any request for registration is
submitted to the Company in accordance with Section 1.4, if so requested, file an Automatic Shelf Registration Statement (as such term is defined in Rule 405 promulgated under the Act) to effect such registration; and 

(o) if at any time when the Company is required to re-evaluate its well-known seasoned issuer status for purposes of an outstanding Automatic
Shelf Registration Statement used to effect a request for registration in accordance with Section 1.4 the Company determines that it is not a well-known seasoned issuer and (i) the registration statement is required to be kept effective in
accordance with this Agreement and (ii) the registration rights of the applicable Holders have not terminated, use commercially reasonable efforts to promptly amend the registration statement on a form the Company is then eligible to use or
file a new registration statement on such form, and keep such registration statement effective in accordance with the requirements otherwise applicable under this Agreement. 

Notwithstanding the provisions of this Section 1, the Company shall be entitled to postpone or suspend, for a reasonable period of time,
the filing, effectiveness or use of, or trading under, any registration statement if the Company shall determine that any such filing or the sale 

  
 9 








 
of any securities pursuant to such registration statement would in the good faith judgment of the Board of Directors of the Company: 

(i) materially impede, delay or interfere with any material pending or proposed financing, acquisition, corporate reorganization or other
similar transaction involving the Company for which the Board of Directors of the Company has authorized negotiations; 
 (ii) materially
adversely impair the consummation of any pending or proposed material offering or sale of any class of securities by the Company; or 

(iii) require disclosure of material nonpublic information that, if disclosed at such time, would be materially harmful to the interests of
the Company and its shareholders; provided, however, that during any such period all executive officers and directors of the Company are also prohibited from selling securities of the Company (or any security of any of the
Company’s subsidiaries or affiliates). 
 In the event of the suspension of effectiveness of any registration statement pursuant to
this Section 1.5, the applicable time period during which such registration statement is to remain effective shall be extended by that number of days equal to the number of days the effectiveness of such registration statement was suspended.

 1.6 Information from Holder. It shall be a condition precedent to the obligations of the Company to take any action pursuant to
this Section 1 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of
such securities as shall be reasonably required to effect the registration of such Holder’s Registrable Securities. 
 1.7 Expenses
of Registration. All expenses other than underwriting discounts and commissions incurred in connection with registrations, filings or qualifications pursuant to Sections 1.2, 1.3 and 1.4, including, without limitation, all registration,
filing and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company and the reasonable fees and disbursements of one counsel for the selling Holders shall be borne by the Company. Notwithstanding the
foregoing, the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 1.2 or Section 1.4 if the registration request is subsequently withdrawn at the request of the Holders of a
majority of the Registrable Securities to be registered (in which case all participating Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn registration), unless, in
the case of a registration requested under Section 1.2, the Holders of a majority of the Registrable Securities agree to forfeit their right to one demand registration pursuant to Section 1.2 and provided, however, that if at
the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable
promptness following disclosure by the Company of such material adverse change, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Sections 1.2 and 1.4. 

  
 10 








 1.8 Delay of Registration. No Holder shall have any right to obtain or seek an injunction
restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 1. 

1.9 Indemnification. In the event any Registrable Securities are included in a registration statement under this Section 1: 

(a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, the partners, members, officers, directors and
shareholders of each Holder, legal counsel and accountants for each Holder, any underwriter (as defined in the Act) for such Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Act or the 1934 Act,
against any losses, claims, damages or liabilities (joint or several) to which they may become subject under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, insofar as such losses, claims,
damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”): (i) any untrue statement or alleged untrue statement
of a material fact contained in such registration statement, including any preliminary prospectus, final prospectus, or Free Writing Prospectus contained therein or any amendments or supplements thereto, any issuer information (as defined in Rule
433 of the Act) filed or required to be filed pursuant to Rule 433(d) under the Act or any other document incident to such registration prepared by or on behalf of the Company or used or referred to by the Company, (ii) the omission or alleged
omission to state in such registration statement a material fact required to be stated therein, or necessary to make the statements therein not misleading or (iii) any violation or alleged violation by the Company of the Act, the 1934 Act, any
state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state securities laws, and the Company will reimburse each such Holder, underwriter, controlling person or other aforementioned person for any legal or
other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred; provided, however, that the indemnity agreement contained in this
subsection l.9(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall
the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation that occurs in reliance upon and in conformity with written information furnished expressly
for use in connection with such registration by any such Holder, underwriter, controlling person or other aforementioned person. 
 (b) To
the extent permitted by law, each selling Holder, severally and not jointly, will indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the
Company within the meaning of the Act, legal counsel and accountants for the Company, any underwriter, any other Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any
losses, claims, damages or liabilities (joint or several) to which any of the foregoing persons may become subject, under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state
securities laws, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and 

  
 11 








 
only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration; and
each such Holder will reimburse any person intended to be indemnified pursuant to this subsection l.9(b) for any legal or other expenses reasonably incurred by such person in connection with investigating or defending any such loss, claim, damage,
liability or action as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection l.9(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or
action if such settlement is effected without the consent of the Holder (which consent shall not be unreasonably withheld), and provided that in no event shall any indemnity under this subsection l.9(b) exceed the net proceeds from the
offering received by such Holder. 
 (c) Promptly after receipt by an indemnified party under this Section 1.9 of notice of the
commencement of any action (including any governmental action) for which a party may be entitled to indemnification, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 1.9,
deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in and, to the extent the indemnifying party so desires, jointly with any other indemnifying party
similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by
one counsel) shall have the right to retain one (1) separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be
inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time
of the commencement of any such action, if prejudicial to its ability to defend such action, shall relieve such indemnifying party of liability to the indemnified party under this Section 1.9 to the extent of such prejudice, but the omission to
so deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 1.9. 

(d) If the indemnification provided for in this Section 1.9 is held by a court of competent jurisdiction to be unavailable to an
indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and the indemnified party on the other hand in connection
with the statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as any other relevant equitable considerations; provided, however, that (i) no contribution by any Holder, when combined
with any amounts paid by such Holder pursuant to Section 1.9(b), shall exceed the net proceeds from the offering received by such Holder and (ii) no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation; and provided further that in no event shall a Holder’s liability pursuant to this Section 1.9(d), when
combined with the amounts paid or payable by such Holder pursuant to Section 1.9(b), exceed the proceeds from the offering received by such Holder (net of any expenses paid by such Holder). The relative fault of the


  
 12 








 
indemnifying party and the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or
omission. 
 (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the
underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

(f) The obligations of the Company and Holders under this Section 1.9 shall survive the completion of any offering of Registrable
Securities in a registration statement under this Section 1 and otherwise. 
 1.10 Reports Under the 1934 Act. With a view to
making available to the Holders the benefits of Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form
S-3, the Company agrees to: 
 (a) make and keep public information available, as those terms are
understood and defined in Rule 144, at all times after the effective date of the Initial Offering; 
 (b) file with the SEC in a
timely manner all reports and other documents required of the Company under the Act and the 1934 Act; and 
 (c) furnish to any Holder, so
long as the Holder owns any Registrable Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of Rule 144 (at any time after ninety (90) days after the effective
date of the first registration statement filed by the Company), the Act and the 1934 Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company and (iii) such other
information as may be reasonably requested to avail any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration or pursuant to such form. 

1.11 Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities pursuant to this
Section 1 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee of such securities that (a) is an Affiliate, subsidiary, parent, partner, limited partner, retired partner or shareholder of a
Holder, (b) is a Holder’s family member or trust for the benefit of an individual Holder, or (c) after such assignment or transfer, holds at least 100,000 shares of Registrable Securities (appropriately adjusted for any stock split,
dividend, combination or other recapitalization), provided: (i) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee or assignee and the securities with
respect to which such registration rights are being assigned; (ii) such transferee or assignee agrees in writing to be 

  
 13 








 
bound by and subject to the terms and conditions of this Agreement, including, without limitation, the provisions of Section 1.13 below; and (iii) such assignment shall be effective
only if immediately following such transfer the further disposition of such securities by the transferee or assignee is restricted under the Act. 

1.12 Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without the prior
written consent of the Holders holding a majority of the Registrable Securities then held by all Holders, enter into any agreement with any holder or prospective holder of any securities of the Company that would allow such holder or prospective
holder (a) to include any of such securities in any registration filed under Section 1.2, Section 1.3 or Section 1.4 hereof, unless under the terms of such agreement, such holder or prospective holder may include such securities
in any such registration only to the extent that the inclusion of such securities will not reduce the amount of the Registrable Securities of the Holders that are included or (b) to demand registration of their securities. 

1.13 “Market Stand-Off” Agreement. 

(a) Each Holder hereby agrees that it will not, without the prior written consent of the managing underwriter, during the period commencing
on the date of the final prospectus relating to the Company’s Initial Offering and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (l80) days) (i) lend, offer, pledge,
sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any
securities convertible into or exercisable or exchangeable for Common Stock held immediately prior to the effectiveness of the Registration Statement for such offering, or (ii) enter into any swap or other arrangement that transfers to another,
in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash or
otherwise. The foregoing provisions of this Section 1.13 shall apply only to the Company’s initial offering of equity securities, shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall
only be applicable to the Holders if all officers, directors and greater than one percent (1%) shareholders of the Company enter into similar agreements. The underwriters in connection with the Company’s Initial Offering are intended third-party beneficiaries of this Section 1.13 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such
agreements as may be reasonably requested by the underwriters in the Company’s Initial Offering that are consistent with this Section 1.13 or that are necessary to give further effect thereto. Any discretionary waiver or termination of the
restrictions of any or all of such agreements by the Company or the underwriters shall apply to all Holders subject to such agreements pro rata based on the number of shares subject to such agreements. 

In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with
respect to the Registrable Securities of each Holder (and the shares or securities of every other person subject to the foregoing restriction) until the end of such period. Notwithstanding the foregoing, if (i) during the last seventeen
(17) days of the one hundred eighty (180)-day restricted period, the Company issues an earnings release or material news or a 

  
 14 








 
material event relating to the Company occurs; or (ii) prior to the expiration of the one hundred eighty (180)-day restricted period, the Company announces that it will release earnings
results during the sixteen (16)-day period beginning on the last day of the one hundred eighty (180)-day period, the restrictions imposed by this Section 1.13 shall continue to apply until the expiration of the eighteen (18)-day period
beginning on the issuance of the earnings release or the occurrence of the material news or material event. 
 (b) Each Holder agrees that
a legend reading substantially as follows shall be placed on all certificates representing all Registrable Securities of each Holder (and the shares or securities of every other person subject to the restriction contained in this Section 1.13):

 THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD AFTER THE EFFECTIVE DATE OF THE ISSUER’S REGISTRATION
STATEMENT FILED UNDER THE ACT, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S PRINCIPAL OFFICE. SUCH LOCK-UP PERIOD IS BINDING ON
TRANSFEREES OF THESE SHARES. 
 1.14 Termination of Registration Rights. No Holder shall be entitled to exercise any right provided
for in this Section 1 (a) after five (5) years following the consummation of the Initial Offering, or (b) as to any Holder, such earlier time after the Initial Offering at which such Holder can sell all shares held by it in any
three (3) month period without registration in compliance with Rule 144. 
 2. Covenants of the Company. 

2.1 Delivery of Financial Statements. The Company shall, upon request, deliver to each Investor (or transferee of an Investor) that
holds at least 750,000 shares of Registrable Securities (appropriately adjusted for any stock split, dividend, combination or other recapitalization) (a “Major Investor”): 

(a) as soon as practicable, but in any event within one hundred twenty (120) days after the end of each fiscal year of the Company, an
income statement for such fiscal year, a balance sheet of the Company and statement of shareholders’ equity as of the end of such year, and a statement of cash flows for such year, such year-end financial
reports to be in reasonable detail, prepared in accordance with generally accepted accounting principles (“GAAP”), and, upon such time as the Board of Directors determines that the Company’s financial statements be audited,
audited and certified by independent public accountants of nationally recognized standing selected by the Company; and 
 (b) as soon as
practicable, but in any event within forty-five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, an unaudited income statement, statement of cash flows for such fiscal quarter and an
unaudited balance sheet as of the end of such fiscal quarter, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments and (ii) not contain all notes thereto that
may be required in accordance with GAAP); and 

  
 15 








 (c) such other information relating to the financial condition, business or corporate affairs of
the Company as the Major Investor may from time to time request, provided, however, that the Company shall not be obligated under this subsection (c) or any other subsection of Section 2.1 to provide information that
(i) it deems in good faith to be a trade secret or similar confidential information or (ii) the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel. 

2.2 Inspection. The Company shall permit each Major Investor, at such Major Investor’s expense, to visit and inspect the
Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its officers, all at such reasonable times as may be requested by the Major Investor; provided,
however, that the Company shall not be obligated pursuant to this Section 2.2 to provide access to any information that it reasonably considers to be a trade secret or similar confidential information. 

2.3 Termination of Information and Inspection Covenants. The covenants set forth in Sections 2.1 and 2.2 shall terminate and be of
no further force or effect upon the earlier to occur of (a) the consummation of the sale of securities pursuant to a registration statement filed by the Company under the Act in connection with the firm commitment underwritten offering of its
securities to the general public, (b) when the Company first becomes subject to the periodic reporting requirements of Sections 12(g) or 15(d) of the 1934 Act, whichever event shall first occur or (c) the consummation of a Liquidation
Event, as that term is defined in the Restated Certificate. 
 2.4 Right of First Offer. Subject to the terms and conditions
specified in this Section 2.4, the Company hereby grants to each Major Investor a right of first offer with respect to future sales by the Company of its Shares (as hereinafter defined). For purposes of this Section 2.4, the term
“Major Investor” includes any general partners and affiliates of a Major Investor. A Major Investor shall be entitled to apportion the right of first offer hereby granted it among itself and its partners and Affiliates in such
proportions as it deems appropriate. 
 Each time the Company proposes to offer any shares of, or securities convertible into or
exchangeable or exercisable for any shares of, its capital stock (“Shares”), the Company shall first make an offering of such Shares to each Major Investor in accordance with the following provisions: 

(a) The Company shall deliver a notice in accordance with Section 3.5 (“Notice”) to the Major Investors stating
(i) its bona fide intention to offer such Shares, (ii) the number of such Shares to be offered and (iii) the price and terms upon which it proposes to offer such Shares. 

(b) By written notification received by the Company within twenty (20) calendar days after the giving of Notice, each Major Investor may
elect to purchase, at the price and on the terms specified in the Notice, up to that portion of such Shares that equals the 

  
 16 








 
proportion that the number of shares of Common Stock that are Registrable Securities issued and held by such Major Investor (assuming full conversion and exercise of all convertible and
exercisable securities then outstanding) bears to the total number of shares of Common Stock of the Company then outstanding (assuming full conversion and exercise of all convertible and exercisable securities then outstanding). The Company shall
promptly, in writing, inform each Major Investor that elects to purchase all the shares available to it (a “Fully-Exercising Investor”) of any other Major Investor’s failure to do likewise. During the ten (10) day period
commencing after such information is given, each Fully-Exercising Investor may elect to purchase that portion of the Shares for which Major Investors were entitled to subscribe, but which were not subscribed
for by the Major Investors, that is equal to the proportion that the number of shares of Registrable Securities issued and held by such Fully-Exercising Investor bears to the total number of shares of Common
Stock of the Company then outstanding (assuming full conversion and exercise of all convertible and exercisable securities then outstanding) held by the Full-Exercising Investors. 

(c) If all Shares that Major Investors are entitled to obtain pursuant to subsection 2.4(b) are not elected to be obtained as provided
in subsection 2.4(b) hereof, the Company may, during the ninety (90) day period following the expiration of the period provided in subsection 2.4(b) hereof, offer the remaining unsubscribed portion of such Shares to any person or
persons at a price not less than that, and upon terms no more favorable to the offeree than those, specified in the Notice. If the Company does not enter into an agreement for the sale of the Shares within such period, or if such agreement is not
consummated within sixty (60) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such Shares shall not be offered unless first reoffered to the Major Investors in accordance herewith. 

(d) The right of first offer in this Section 2.4 shall not be applicable to (i) shares of Common Stock (or options therefor) issued
to employees, directors, consultants and other service providers for the primary purpose of soliciting or retaining their services pursuant to plans or agreements approved by the Company’s Board of Directors; (ii) the issuance of
securities pursuant to a bona fide, firmly underwritten public offering of shares of Common Stock pursuant to a registration statement under the Act resulting in proceeds to the Company of at least $30,000,000 in the aggregate, (iii) the
issuance of securities pursuant to the conversion or exercise of convertible or exercisable securities, (iv) the issuance of securities in connection with a bona fide business acquisition of or by the Company, whether by merger, consolidation,
sale of assets, sale or exchange of stock or otherwise, provided that such issuances are approved by the Company’s Board of Directors, including at least one of the Preferred Directors (as such term is defined in the Restated Certificate),
(v) the issuance of stock, warrants or other securities or rights to persons or entities with which the Company has business relationships, provided such issuances are approved by the Company’s Board of Directors, including at least
one of the Preferred Directors (as such term is defined in the Restated Certificate), and are primarily for other than equity financing purposes, (vi) the issuance of securities pursuant to any equipment leasing arrangement or debt financing
arrangement, which arrangement is approved by the Board of Directors, including at least one of the Preferred Directors (as such term is defined in the Restated Certificate), and is primarily for non-equity financing purposes, (vii) the
issuance of stock, warrants or other securities as a bona fide gift to any charitable organization described in Section 501(c)(3) of the Internal Revenue Code, provided such issuances are approved by the Board, including at least one
(1) of the Preferred Directors, and are for non-equity financing 

  
 17 








 
purposes, or (viii) the issuance of Shares (as defined in the Series F Agreement), or any securities issued pursuant to the conversion thereof, issued pursuant to Section 1.3 of the
Series F Agreement. In addition to the foregoing, the right of first offer in this Section 2.4 shall not be applicable with respect to any Major Investor in any subsequent offering of Shares if (i) at the time of such offering, the Major
Investor is not an “accredited investor,” as that term is then defined in Rule 501(a) of the Act and (ii) such offering of Shares is otherwise being offered only to accredited investors. 

(e) The rights provided in this Section 2.4 may not be assigned or transferred by any Major Investor; provided, however,
that a Major Investor that is a venture capital fund may assign or transfer such rights to its Affiliates. 
 2.5 Proprietary Information
and Inventions Agreements. The Company shall require all employees and consultants with access to confidential information to execute and deliver a Proprietary Information and Inventions Agreement in substantially the form approved by the
Company’s Board of Directors. 
 2.6 Employee Agreements. Unless approved by the Board of Directors of the Company, all future
employees of the Company who shall purchase, or receive options to purchase, shares of Common Stock following the date hereof shall be required to execute stock purchase or option agreements providing for (a) vesting of shares over a four
(4) year period with the first twenty-five percent (25%) of such shares vesting following twelve (12) months of continued employment or services, and the remaining shares vesting in equal monthly installments over the following thirty
six (36) months thereafter and (b) a one hundred and eighty (180)-day lockup period (plus an additional period of up to eighteen (18) days) in connection with the Company’s initial public offering. The Company shall retain a
right of first refusal on transfers until the Company’s initial public offering and the right to repurchase unvested shares at cost. 

2.7 Insurance. The Company shall use commercially reasonable efforts to maintain Directors and Officers liability insurance from a
financially sound and reputable insurer in such amount and on such terms as determined by the Company’s Board of Directors, including at least one of the Preferred Directors (as such term is defined in the Restated Certificate), until such time
as the Company’s Board of Directors, including at least one of the Preferred Directors (as such term is defined in the Restated Certificate), determines that such insurance should be discontinued. 

2.8 Observer Rights. As long as Khosla Ventures IV, L.P. and/or its affiliates (“Khosla”) owns not less than 1,500,000 shares
(appropriately adjusted for any stock split, dividend, combination or other recapitalization) of Series B Preferred Stock (or an equivalent amount of Common Stock issued upon conversion thereof), the Company shall invite a representative of
Khosla to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents and other materials that it provides to its directors;
provided, however, that such representative shall agree to hold in confidence and not to use or disclose any information so provided; and, provided further, that the Company reserves the right to withhold any information
and to exclude such representative from any meeting or portion thereof if access to such 

  
 18 








 
information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel or would result in
disclosure of trade secrets to such representative or if such Investor or its representative is or is affiliated with a direct competitor of the Company. 

2.9 FCPA; OFAC. The Company represents that it shall not, and shall not permit any of its subsidiaries or Affiliates or any of its or
their respective directors, officers, managers, employees, independent contractors, representatives or agents to, promise, authorize or make any payment to, or otherwise contribute any item of value to, directly or indirectly, to any third party,
including any Non-U.S. Official, in each case, in violation of the Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”), the U.K. Bribery Act (the “Bribery Act”), or any other applicable anti-bribery or anti-corruption
law. The Company further represents that it shall, and shall cause each of its subsidiaries and Affiliates to, cease all of its or their respective activities, as well as remediate any actions taken by the Company, its subsidiaries or Affiliates, or
any of their respective directors, officers, managers, employees, independent contractors, representatives or agents in violation of the FCPA, the Bribery Act, or any other applicable anti-bribery or anti-corruption law. The Company further
represents that it shall, and shall cause each of its subsidiaries and Affiliates to, maintain systems of internal controls (including, but not limited to, accounting systems, purchasing systems and billing systems) to ensure compliance with the
FCPA, the Bribery Act, or any other applicable anti-bribery or anti-corruption law. The Company is aware of the sanctions and requirements imposed by the U.S. Department of the Treasury’s Office of Foreign Assets Control and European Union in
response to the events in Ukraine, Crimea and Sevastopol (the “OFAC Requirements”). To its knowledge, the Company is in material compliance with the OFAC Requirements to the extent such sanctions are applicable to the
Company’s business as presently conducted. 
 2.10 Green Dot Corporation. The Company shall not enter into any banking or
nonbanking transaction with Green Dot Corporation or any of its subsidiaries (Next Estate Communications and Bonneville Bancorp) without the prior written consent of Sequoia. 

2.11 Investment; Acknowledgment. The Company acknowledges that the Investors and their affiliates, members, equity holders, director
representatives, partners, employees, agents and other related persons are engaged in the business of investing in private and public companies in a wide range of industries, including the industry segment in which the Company operates (the
“Company Industry Segment”). Accordingly, the Company and the Investors acknowledge and agree that a Covered Person shall: 
 (a)
have no obligation or duty (contractual or otherwise) to the Company to refrain from participating as a director, investor or otherwise with respect to any company or other person or entity that is engaged in the Company Industry Segment or is
otherwise competitive with the Company, and 
 (b) in connection with making investment decisions, to the fullest extent permitted by law,
have no obligation or duty (contractual or otherwise) to the Company to refrain from using any information, including, but not limited to, market trend and market data, which comes into such Covered Person’s
possession, whether as a director, investor or otherwise (the “Information Waiver”); provided, that the Information Waiver shall not apply, and therefore 

  
 19 








 
such Covered Person shall be subject to such obligations and duties as would otherwise apply to such Covered Person under applicable law; if the information at issue (i) constitutes material
non-public information concerning the Company, or (ii) is covered by a contractual obligation of confidentiality to which the Company is subject. 

Notwithstanding anything in this Section 2.11 to the contrary, nothing herein shall be construed as a waiver of any Covered Person’s
duty of loyalty or obligation of confidentiality with respect to the disclosure of confidential information of the Company.
 For the
purposes of this Section 2.11, “Covered Persons” shall have the meaning set forth in the Restated Certificate. 
 2.12
Termination of Covenants. The covenants set forth in Section 2 shall terminate and be of no further force or effect upon the consummation of (a) the Company’s sale of its Common Stock or other securities pursuant to a
registration statement under the Act (other than a registration statement relating either to sale of securities to employees of the Company pursuant to its stock option, stock purchase or similar plan or a SEC Rule 145 transaction) resulting in
proceeds to the Company of at least $30,000,000 in the aggregate (other than a registration statement relating either to the sale of securities to employees of the Company pursuant to its stock option, stock purchase or similar plan or a transaction
under Rule 145 of the Act) or (b) a Liquidation Event, as that term is defined in the Restated Certificate. 
 3. Miscellaneous.

 3.1 Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the
benefit of and be binding upon the respective successors and assigns of the parties (including transferees of any shares of Registrable Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party other than the
parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

3.2 Governing Law. This Agreement shall be governed by and construed under the laws of the State of California as applied to agreements
among California residents entered into and to be performed entirely within California. 
 3.3 Counterparts; Facsimile. This
Agreement may be executed and delivered by facsimile or electronic signature and in two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one (1) and the same instrument. 

3.4 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement. 
 3.5 Notices. All notices and other communications given or made pursuant hereto shall
be in writing and shall be deemed effectively given upon the earlier to occur of actual receipt or: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal
business hours of the recipient; if 

  
 20 








 
not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day
after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the respective parties at the addresses set forth on the signature pages attached
hereto (or at such other addresses as shall be specified by notice given in accordance with this Section 3.5). 
 3.6 Expenses.
If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which
such party may be entitled. 
 3.7 Entire Agreement; Amendments and Waivers. This Agreement (including the Exhibits hereto, if any)
constitutes the full and entire understanding and agreement among the parties with regard to the subjects hereof and thereof. Any term of this Agreement (other than Section 2.1, Section 2.2, Section 2.3 and Section 2.4) may be
amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Investors holding a majority of the
Registrable Securities; provided however that (a) the provisions of Section 2.1, Section 2.2, Section 2.3 and Section 2.4 may be amended or waived (either generally or in a particular instance and either retroactively or
prospectively) only with the written consent of the Company and the Major Investors holding a majority of the Registrable Securities that are held by all of the Major Investors and (b) Khosla’s rights under Section 2.8 shall not be
waived or amended without Khosla’s written consent. Any amendment or waiver effected in accordance with this paragraph shall be binding upon each holder of any Registrable Securities, each future holder of all such Registrable Securities and
the Company. 
 3.8 Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be
effective and valid under applicable law, but if any provision of this Agreement shall be held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without
invalidating the remainder of such provision or the remaining provisions of this Agreement. 
 3.9 Aggregation of Stock. All shares
of Registrable Securities held or acquired by affiliated entities (including affiliated venture capital funds or venture capital funds under common investment management) or persons shall be aggregated together for the purpose of determining the
availability of any rights under this Agreement. 
 3.10 Additional Investors. Notwithstanding Section 3.7, no consent shall be
necessary to add additional Investors as signatories to this Agreement, provided that such Investors have purchased Series F Preferred Stock pursuant to the subsequent closing provisions of Section 1.3 of the Series F Agreement. 

3.11 Termination of Prior Agreement. Upon the effectiveness of this Agreement, the Prior Agreement shall terminate and be of no further
force and effect, and shall be superseded and replaced in its entirety by this Agreement. 

  
 21 








 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 22 








 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

							
		 		 	OKTA, INC.
				
		 		 	By:	 	 /s/ Todd McKinnon

		 		 	Name:	 	Todd McKinnon
		 		 	Title:	 	President
		 	Address:	 	301 Brannan Street, 1st Floor
		 		 	San Francisco, CA 94107


  

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT FOR OKTA, INC.









 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

							
		 		 	INVESTOR:
			
		 		 	KHOSLA VENTURES IV, L.P.
				
		 		 	By:	 	Khosla Ventures Associates IV, LLC, a Delaware limited liability company and general partner of Khosla Ventures IV, LP
				
		 		 	By:	 	 /s/ David Weiden

		 		 	Name:	 	David Weiden
		 		 	Title:	 	Member
			
		 	Address:	 	2128 Sand Hill Road
		 		 	Menlo Park, CA 94025
		 		 	Attn: Legal


  

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT FOR OKTA, INC.









 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

							
		 		 	INVESTOR:
			
		 		 	KHOSLA VENTURES IV (CF), L.P.
				
		 		 	By:	 	Khosla Ventures Associates IV, LLC, a Delaware limited liability company and general partner of Khosla Ventures IV (CF), LP
				
		 		 	By:	 	 /s/ David Weiden

		 		 	Name:	 	David Weiden
		 		 	Title:	 	Member
			
		 	Address:	 	2128 Sand Hill Road
		 		 	Menlo Park, CA 94025
		 		 	Attn: Legal


  

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT FOR OKTA, INC.









 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

							
		 		 	INVESTOR:
			
		 		 	GREYLOCK XIII LIMITED PARTNERSHIP
			
		 		 	By: Greylock XIII GP LLC, its General Partner
				
		 		 	By:	 	 /s/ Donald A. Sullivan

		 		 	Name:	 	Donald A. Sullivan
		 		 	Title:	 	Administrative Partner
			
		 		 	GREYLOCK XIII-A LIMITED PARTNERSHIP
			
		 		 	By: Greylock XIII GP LLC, its General Partner
				
		 		 	By:	 	 /s/ Donald A. Sullivan

		 		 	Name:	 	Donald A. Sullivan
		 		 	Title:	 	Administrative Partner
			
		 		 	GREYLOCK XIII PRINCIPALS LLC
			
		 		 	By: Greylock Management Corporation, Sole Member
				
		 		 	By:	 	 /s/ Donald A. Sullivan

		 		 	Name:	 	Donald A. Sullivan
		 		 	Title:	 	Administrative Partner
			
		 	Address:	 	2550 Sand Hill Road, Suite 200
		 		 	Menlo Park, CA 94025
		 		 	Attn: Donald A. Sullivan


  

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT FOR OKTA, INC.









 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

							
		 		 	INVESTOR:
			
		 		 	SEQUOIA CAPITAL U.S. GROWTH FUND VI, L.P.
			
		 		 	SEQUOIA CAPITAL U.S. GROWTH VI PRINCIPALS FUND, L.P.
			
		 		 	Each a Cayman Islands exempted limited partnership
			
		 		 	 By: SC U.S. GROWTH VI MANAGEMENT, L.P.

a Cayman Islands exempted limited partnership, General Partner of Each

			
		 		 	 By: SC US (TTGP), LTD.,
 a Cayman
Islands exempted company, its General Partner

				
		 		 	By:	 	 /s/ Patrick Grady

		 		 	Name:	 	Patrick Grady
		 		 	Title:	 	Director
			
		 	Address:	 	2800 Sand Hill Road, Suite 101
		 		 	Menlo Park, CA 94025
		 		 	Attn: Stephanie Wei


  

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT FOR OKTA, INC.









 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

							
		 		 	INVESTOR:
			
		 		 	SC US GF V HOLDINGS, LTD.
		 		 	a Cayman Islands exempted company
			
		 		 	 By: SEQUOIA CAPITAL U.S. GROWTH FUND V, L.P.

SEQUOIA CAPITAL USGF PRINCIPALS FUND V, L.P.

		 		 	both Cayman Islands exempted limited partnerships, its Members
			
		 		 	 By: SCGF V MANAGEMENT, L.P.,
 a
Cayman Islands exempted limited partnership, its General Partner

			
		 		 	 By: SC US (TTGP), LTD.,
 a Cayman
Islands exempted company, its General Partner

				
		 		 	By:	 	 /s/ Patrick Grady

		 		 	Name:	 	Patrick Grady
		 		 	Title:	 	Director
			
		 	Address:	 	2800 Sand Hill Road, Suite 101
		 		 	Menlo Park, CA 94025
		 		 	Attn: Stephanie Wei


  

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT FOR OKTA, INC.









 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

							
		 		 	INVESTOR:
			
		 		 	AH PARALLEL FUND IV, L.P.
		 		 	for itself and as nominee for
		 		 	AH Parallel Fund IV-A, L.P.,
		 		 	AH Parallel Fund IV-B, L.P. and
		 		 	AH Parallel Fund IV-Q, L.P.
				
		 		 	By:	 	AH Equity Partners IV (Parallel), L.L.C.
		 		 		 	Its general partner
				
		 		 	By:	 	 /s/ Ben Horowitz

		 		 	Name:	 	Ben Horowitz
		 		 	Title:	 	Managing Member
			
		 	Address:	 	2865 Sand Hill Road, Suite 101
		 		 	Menlo Park, CA 94025
		 		 	Attn: Ryan Ward


  

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT FOR OKTA, INC.









 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

							
		 		 	INVESTOR:
			
		 		 	ANDREESSEN HOROWITZ FUND I, L.P.
		 		 	as nominee for
		 		 	Andreessen Horowitz Fund I, L.P.
		 		 	Andreessen Horowitz Fund I-A, L.P. and
		 		 	Andreessen Horowitz Fund I-B, L.P.
			
		 		 	 By: AH Equity Partners I, L.L.C.

Its general partner

				
		 		 	By:	 	 /s/ Ben Horowitz

		 		 	Name:	 	Ben Horowitz
		 		 	Title:	 	Managing Member
			
		 	Address:	 	2865 Sand Hill Road, Suite 101
		 		 	Menlo Park, CA 94025
		 		 	Attn: Ryan Ward


  

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT FOR OKTA, INC.









 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

							
		 		 	INVESTOR:
			
		 		 	ALTIMETER PRIVATE PARTNERS FUND I, L.P.
				
		 		 	By:	 	Altimeter Private General Partner, LLC
		 		 		 	Its General Partner
				
		 		 	By:	 	 /s/ John J. Kiernan III

		 		 	Name:	 	John J. Kiernan III
		 		 	Title:	 	Member
			
		 	Address:	 	One International Place, Suite 2400
		 		 	Boston, MA 02110


  

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT FOR OKTA, INC.









 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

							
		 		 	INVESTOR:
			
		 		 	GLYNN PARTNERS III, L.P.
				
		 		 	By:	 	Glynn Management III LLC
		 		 	Its:	 	General Partner
				
		 		 	By:	 	 /s/ Scott Jordan

		 		 	Name:	 	Scott Jordan
		 		 	Title:	 	Managing Director
			
		 		 	GLYNN PARTNERS IV, L.P.
				
		 		 	By:	 	Glynn Management IV, LLC
		 		 	Its:	 	General Partner
				
		 		 	By:	 	 /s/ Scott Jordan

		 		 	Name:	 	Scott Jordan
		 		 	Title:	 	Managing Director
			
		 	Address:	 	Glynn Capital Management LLC
		 		 	3000 Sand Hill Road, Bldg 3, 230
		 		 	Menlo Park, CA 94025


  

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT FOR OKTA, INC.









 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

							
			
		 		 	INVESTOR:
			
		 		 	H. BARTON CO-INVEST FUND II, LLC
				
		 		 	By:	 	H. Barton Asset Management, LLC
		 		 	Its:	 	Managing Member
				
		 		 	By:	 	 /s/ Harris Barton

		 		 	Name:	 	Harris Barton
		 		 	Title:	 	Managing Member
			
		 	Address:	 	2882 Sand Hill Road, Suite 241
		 		 	Menlo Park, CA 94025
			
		 	Mailing Address:	 	c/o KLH & Associates
		 		 	135 Main Street, 9th Floor
		 		 	San Francisco, CA 94105


  

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT FOR OKTA, INC.









 SCHEDULE A 

SCHEDULE OF INVESTORS 
 Andreessen
Horowitz Fund I, L.P. 
 Dharmesh Shah 
 Stephen Marcus 

Edward Roberts, Trustee for the Edward B. Roberts Trust – 2003 

Avid Larizadeh 
 Marc Kerrest 

Jacques D. Kerrest and Sandra W. Kerrest TTEE Jacques & Sandra Kerrest Revocable Trust U/A DTD 05/09/1995 

Thomas A. Berson and Dorothy A. Berson as Trustees of the Berson Living Trust UTA DTD 5/24/1983 

Maynard and Irene Webb, Trustees for the Webb Family Trust u/a 6/03/95 

G&H Partners 
 Maples Investments II, L.P. 

Maples Associates II, L.P. 
 SV Angel LLC 

Greylock XIII Limited Partnership 
 Greylock XIII-A Limited
Partnership 
 Greylock XIII Principals LLC 
 Khosla Ventures
IV, L.P. 
 Khosla Ventures IV (CF), LP 
 The David A. Duffield
Trust 
 Allen & Company LLC 
 SC US GF V Holdings,
Ltd. 
 Sequoia Capital U.S. Growth Fund VI, L.P. 
 Sequoia
Capital U.S. Growth VI Principals Fund, L.P. 
 AH Parallel Fund IV, L.P., as nominee 

H. Barton Co-Invest Fund II, LLC 
 Janus Global Technology Fund, a
Series of Janus Investment Fund 
 Global Technology Portfolio, a Series of Janus Aspen Series 

Altimeter Private Partners Fund I, L.P. 
 AME Cloud Ventures, LLC

 Glynn Partners IV, L.P. 
 Glynn Partners III, L.P. 

  
 S-1